DEFA14A: Foghorn Therapeutics Sets Date for Annual Stockholders Meeting

Sentiment:

Proxy Statement


Foghorn Therapeutics will hold its annual stockholders meeting on June 26, 2024, to elect directors and ratify the selection of its independent auditor.

Summary

  • Foghorn Therapeutics Inc. will hold its Annual Meeting of Stockholders on Wednesday, June 26, 2024, at 9:00 AM Eastern Time.
  • The meeting will be held live via the internet, and stockholders can register and participate at www.proxydocs.com/FHTX.
  • Stockholders of record as of April 29, 2024, are eligible to vote.
  • The agenda includes the election of three Class I directors (Scott Biller, Thomas J. Lynch, and Michael Mendelsohn) for three-year terms.
  • The agenda also includes the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the company for the fiscal year ending December 31, 2024.
  • Stockholders can access proxy materials and vote online at www.proxydocs.com/FHTX using their 12-digit control number.
  • Paper copies of the proxy materials can be requested until June 14, 2024.

Sentiment

Score: 5

Explanation: The document is a neutral announcement of a routine corporate event.

Positives

  • Stockholders have multiple options for accessing proxy materials and voting, including online and by requesting paper copies.
  • The company is adhering to SEC rules by making proxy materials available on the internet.

Industry Context

This is a standard annual meeting announcement, typical for publicly traded companies to fulfill their corporate governance obligations.

Stakeholder Impact

  • Shareholders are asked to vote on key proposals related to the company's governance.
  • The outcome of the votes will influence the composition of the board of directors and the selection of the company's auditor.

Next Steps

  • Stockholders should review the proxy materials and vote on the proposals.
  • The company will hold the Annual Meeting on June 26, 2024.

Key Dates

DateDescription
April 29, 2024Record date for stockholders eligible to vote at the Annual Meeting
June 14, 2024Deadline to request paper copies of proxy materials in time for the Annual Meeting
June 26, 2024Date of the Annual Meeting of Stockholders
December 31, 2024Fiscal year end for which Deloitte & Touche LLP is proposed as the independent auditor

Keywords

Annual Meeting, Stockholders, Proxy Statement, Directors, Auditor, Voting, Foghorn Therapeutics, Deloitte & Touche

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.